Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Mobix Labs, Inc. (MOBX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a fabless semiconductor and connectivity issuer listed on The Nasdaq Capital Market. Through these documents, investors can review how Mobix Labs reports on its RF, connectivity, interconnect and EMI filtering business, its capital structure and its financing activities.
Current and periodic reports such as Form 8‑K detail material events, including at‑the‑market offering agreements, warrant exercise inducement transactions, debt and equity financings, Nasdaq minimum bid‑price notices and extensions, and amendments to outstanding warrants that affect classification of these instruments as equity or liabilities. Certain 8‑K and 8‑K/A filings also describe leadership changes and advisory roles, as well as legal proceedings related to alleged failures to fund agreed‑upon investments.
Registration statements on Form S‑1 and Form S‑3, along with their amendments, outline registered offerings of Mobix Labs’ Class A common stock and the use of proceeds the company identifies, such as working capital, general corporate purposes, growth initiatives and M&A strategy. These filings also provide background on the company’s fabless semiconductor model, RF and connectivity focus, and risk factors.
Annual and quarterly reports on Forms 10‑K and 10‑Q, when filed, give a broader view of Mobix Labs’ financial condition, including revenue, gross margin, operating loss and liquidity metrics, as well as segment and market discussions. Preliminary, unaudited financial information referenced in news releases is later finalized in these periodic reports.
On Stock Titan, Mobix Labs filings are updated in near real time from EDGAR. AI‑powered summaries help explain complex sections of 10‑K and 10‑Q reports, highlight key points from 8‑K disclosures, and make it easier to interpret warrant, debt and equity terms. Users can also review ownership and insider‑related information when available through Forms 3, 4 and 5 to understand equity incentives and changes in beneficial holdings.
Mobix Labs, Inc. has filed a resale registration statement covering up to 2,500,000 shares of Class A Common Stock issuable upon conversion of a $3,000,000 senior secured convertible promissory note held by Leviston Resources. All registered shares may be sold from time to time by the selling stockholder, and Mobix will not receive proceeds from these resales.
The company states that, assuming full issuance, the registered shares would equal about 23.94% of Class A Common Stock outstanding as of April 16, 2026, creating a potential overhang that could pressure the stock price. Mobix’s Class A stock is listed on Nasdaq under “MOBX,” and there is an existing 1‑for‑10 Reverse Stock Split already reflected in share figures.
Mobix highlights significant risks: it is an early-stage business with recurring operating losses, substantial doubt about its ability to continue as a going concern, heavy customer concentration, the need to raise additional capital, Nasdaq listing compliance concerns, and identified material weaknesses in internal control over financial reporting.
Mobix Labs, Inc. files a prospectus supplement registering up to 2,412,711 shares of Class A common stock. The supplement updates the prospectus with information from Current Reports on Form 8-K filed April 3, 2026 and April 9, 2026. The company’s Class A shares trade on Nasdaq under the symbol MOBX; the closing price was $3.04 on April 8, 2026.
Mobix Labs, Inc. implemented a one-for-ten reverse stock split of its Class A and Class B Common Stock, effective at 4:00 p.m. Eastern Time on April 6, 2026. Every 10 shares of common stock were converted into 1 share, with cash paid instead of issuing fractional shares.
The reverse split leaves each stockholder’s percentage ownership essentially unchanged and does not affect the par value or authorized share count. The company is proportionately adjusting shares available under its equity incentive plan and outstanding options and warrants, and each warrant now covers one-tenth of a share at an exercise price of $57.90.
Mobix Labs, Inc. entered into a financing deal with Leviston Resources via a senior secured convertible promissory note with an original principal amount of $3,000,000, sold for $2,550,000. The note bears 10% annual interest from March 31, 2026 and matures on July 31, 2026, when unpaid principal and interest are due in cash unless converted earlier.
Leviston may convert principal and interest into Class A common stock at a price equal to the lesser of the closing price on March 31, 2026 and 85% of the lowest 8-day VWAP before and including the conversion notice date. Following an event of default, obligations increase to 125% of amounts then outstanding. Mobix agreed to file and seek effectiveness of a registration statement to allow resales of conversion shares under the Securities Act.
Mobix Labs, Inc. files a Prospectus Supplement amending its Form S-1 to register up to 24,127,116 shares of Class A Common Stock.
The supplement incorporates a Form 8-K disclosing results from the March 23, 2026 Annual Meeting: holders representing 43,982,421 Class A shares and 2,004,901 Class B shares (approximately 52.86% voting power as of February 27, 2026) were present or represented. Stockholders approved director elections, ratification of the independent auditor, a reverse stock split proposal, and a warrant proposal. The Company’s Class A shares trade on Nasdaq under MOBX, with a closing price of $0.4588 on March 24, 2026.
Mobix Labs, Inc. reported the results of its Annual Meeting of Stockholders held on March 23, 2026. Holders of 43,982,421 shares of Class A Common Stock and 2,004,901 shares of Class B Common Stock were represented, accounting for approximately 52.86% of the total voting power as of the February 27, 2026 record date, which constituted a quorum.
Stockholders elected Class A director nominees David Aldrich and Frederick Goerner, and Class B director nominee Keyvan Samini, with substantial majorities. They also ratified the selection of the independent registered public accounting firm, approved a Reverse Stock Split Proposal, and approved a Warrant Proposal, each with strong levels of support and no broker non-votes recorded.
Mobix Labs, Inc. registers the resale of up to 24,127,116 shares of Class A Common Stock by selling stockholders. The resale prospectus covers Offered Securities held by third parties (including 1,268,252 Warrant Shares and 3,856,854 RaGE consideration shares) and states the company will not receive proceeds from resale by the Selling Stockholders.
The prospectus discloses 101,072,226 shares of Class A Common Stock outstanding as of January 31, 2026. It also states that, if certain warrants are exercised for cash, the company would receive aggregate gross proceeds of approximately $15.6 million. The filing warns that the Offered Securities would represent approximately 23.9% of outstanding Class A shares as of January 31, 2026 and that such sales could materially depress the market price.
Mobix Labs, Inc. is asking stockholders to approve four key items at its 2026 virtual annual meeting. Investors will vote on electing Class II directors, ratifying PricewaterhouseCoopers LLP as auditor for the year ending September 30, 2026, and a reverse stock split.
The reverse split would reclassify and combine outstanding Class A and Class B shares at a ratio between 1:10 and 1:50, at the Board’s discretion, primarily to help regain compliance with Nasdaq’s $1.00 minimum bid price after a prior deficiency notice and extension through April 27, 2026.
Stockholders are also asked to approve, under Nasdaq Listing Rule 5635(d), potential issuance of up to 8,229,701 Class A shares on exercise of an Inducement Warrant, 384,053 shares on Placement Agent Warrants, and 1,000,000 shares on an additional warrant related to amended outstanding warrants.
Mobix Labs, Inc. announced that its board of directors approved an amendment and restatement of the company’s bylaws effective February 27, 2026. The key change lowers the quorum requirement for stockholder meetings from a majority of voting power to one-third of the voting power of outstanding shares entitled to vote, unless otherwise required by law, the certificate of incorporation or applicable stock exchange rules.
The full text of the amended and restated bylaws, including the revised quorum language in Section 1.5, is provided as Exhibit 3.1 to this report.